Invention Grant
- Patent Title: Glucose-responsive microgels for closed loop insulin delivery
- Patent Title (中): 用于闭环胰岛素递送的葡萄糖反应性微凝胶
-
Application No.: US14379481Application Date: 2013-02-19
-
Publication No.: US09339529B2Publication Date: 2016-05-17
- Inventor: Daniel G. Anderson , Zhen Gu , Robert S. Langer
- Applicant: Massachusetts Institute of Technology , The Children's Medical Center Corporation
- Applicant Address: US MA Cambridge US MA Boston
- Assignee: Massachusetts Institute of Technology,The Children's Medical Center Corporation
- Current Assignee: Massachusetts Institute of Technology,The Children's Medical Center Corporation
- Current Assignee Address: US MA Cambridge US MA Boston
- Agency: Pabst Patent Group LLP
- International Application: PCT/US2013/026633 WO 20130219
- International Announcement: WO2013/123492 WO 20130822
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K38/28 ; A61K38/44 ; A61K9/50 ; A61K9/51

Abstract:
Injectable insulin loaded microgels that are capable of modifying the amount of insulin released based on the patient's tissue glucose levels, methods for making and using these compositions have been developed. The microgels contain insulin, glucose oxidase entrapped in or bound to the microgels, and an agent that reduces hydrogen peroxide, entrapped in or bound to the microgels, wherein the polymeric microgel expands when pH decreases from physiological pH and shrinks when pH increases towards physiological pH, thereby releasing insulin at a rate corresponding to the glucose concentration. In one embodiment, the glucose oxidase and/or the agent reducing hydrogen peroxide are encapsulated in nanogels, then encapsulated within the microgel.
Public/Granted literature
- US20150030641A1 GLUCOSE-RESPONSIVE MICROGELS FOR CLOSED LOOP INSULIN DELIVERY Public/Granted day:2015-01-29
Information query